Synthesis and Characterization of trans-Dichlorotetrakis(imidazole)cobalt(III) Chloride: A New Cobalt(III) Coordination Complex with Potential Prodrug Properties
Open Access
- 3 September 2018
- journal article
- research article
- Published by Wiley in Bioinorganic Chemistry and Applications
- Vol. 2018, 1-7
Abstract
Numerous therapies for the treatment of cancer have been explored with increasing evidence that the use of metal-containing compounds could prove advantageous as anticancer therapeutics. Previous works on Ru(III) complexes suggest that structurally similar Co(III) complexes may provide good alternative, low-cost, effective prodrugs. Herein, a new complex, trans-[Co(imidazole)4Cl2]Cl (2), has been synthesized in high yields utilizing ligand exchange under refluxing conditions. The structure of 2 has been characterized by elemental analysis, 1H and 13C·NMR, ESI-MS, CV, and UV-Vis. The ability of 2 to become reduced in the presence of ascorbic acid was probed demonstrating the likely reduction of the Co(III) metal center to Co(II). In addition, preliminary cell line testing on 2 shows a lack of cytotoxicity.Keywords
Funding Information
- National Institutes of Health (5T34GM092711-04)
- Fort Lewis College (5T34GM092711-04)
This publication has 41 references indexed in Scilit:
- Lawsone Dimerization in Cobalt(III) Complexes toward the Design of New Prototypes of Bioreductive ProdrugsInorganic Chemistry, 2013
- Redox activation of metal-based prodrugs as a strategy for drug deliveryAdvanced Drug Delivery Reviews, 2012
- Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugsDalton Transactions, 2011
- Characterization of a Ruthenium(III)/NAMI‐A Adduct with Bovine Serum Albumin that Exhibits a High Anti‐Metastatic ActivityAngewandte Chemie International Edition, 2010
- Current applications and future potential for bioinorganic chemistry in the development of anticancer drugsDrug Discovery Today, 2009
- New trends for metal complexes with anticancer activityCurrent Opinion in Chemical Biology, 2008
- Metal-Based TherapeuticsScience, 2007
- Synthesis, Structural Characterization, Solution Chemistry, and Preliminary Biological Studies of the Ruthenium(III) Complexes [TzH][trans-RuCl4(Tz)2] and [TzH][trans-RuCl4(DMSO)(Tz)]·(DMSO), the Thiazole Analogues of Antitumor ICR and NAMI-AInorganic Chemistry, 2004
- Synthesis, structures and hypoxia-selective cytotoxicity of cobalt(III) complexes containing tridentate amine and nitrogen mustard ligandsJ. Chem. Soc., Dalton Trans., 2000
- Kinetics of solvolysis of the trans-dichlorotetrapyridinecobalt(III) ion in water and in water + methanolJ. Chem. Soc., Dalton Trans., 1980